V. Leblond

5.9k citations
95 papers · 4.0k · h-index 35

Impact in

  • Hematology top 0.5%
    • Hematopoietic Stem Cell Transplantation
    • Acute Myeloid Leukemia Research
  • Genetics top 1%
    • Chronic Lymphocytic Leukemia Research

Papers in

    • Chronic Lymphocytic Leukemia Research 27
    • Viral-associated cancers and disorders 12

V. Leblond

92 papers receiving 3.8k citations

Peers

V. Leblond
Comparison fields: 5 of 97
  • Hematology 1.2k
  • Genetics 847
  • Pathology and Forensic Medicine 1.2k
  • Oncology 1.6k
  • Immunology 781
Replace John P. Greer with:
John P. Greer United States
Javier Briones Spain
Anne Parker United Kingdom
Donald E. Tsai United States
Silvia Montoto United Kingdom
Lode J. Swinnen United States
Francesca Bonifazi Italy
Réda Bouabdallah France
Monique C. Minnema Netherlands
Kosei Matsue Japan
V. Leblond relative to John P. Greer United States John P. Greer's profile →
Citations per field
00.5×1.5×2×
John P. Greer · 1×
Citations per year

Countries citing papers authored by V. Leblond

Since Specialization
Citations

This map shows the geographic impact of V. Leblond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Leblond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Leblond more than expected).

Fields of papers citing papers by V. Leblond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Leblond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Leblond. The network helps show where V. Leblond may publish in the future.

Co-authors

The 25 scholars most cited alongside V. Leblond, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with V. Leblond Line = papers co-authored together V. Leblond links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2000309
2 1998291
3 1987242
4 1995226
5 1998200
6 2013133
7 1995127
8 1994122
9 2003110
10 1993105
11 2007100
12 201295
13 199591
14 199189
15 200386
16 199875
17 201273
18 200172
19 199671
20 200770

About V. Leblond

V. Leblond is a scholar working on Genetics, Oncology, Hematology, Pathology and Forensic Medicine and Neurology, having authored 95 papers that have together received 4.0k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (27 papers), Lymphoma Diagnosis and Treatment (21 papers), Hematopoietic Stem Cell Transplantation (12 papers), CNS Lymphoma Diagnosis and Treatment (12 papers), Viral-associated cancers and disorders (12 papers), Acute Myeloid Leukemia Research (9 papers), Multiple Myeloma Research and Treatments (8 papers) and Chronic Myeloid Leukemia Treatments (7 papers). The work is most often cited by research in Hematology (1.2k citations), Genetics (847 citations), Pathology and Forensic Medicine (1.2k citations), Oncology (1.6k citations) and Immunology (781 citations). V. Leblond has collaborated with scholars based in France, Germany and United States. Frequent co-authors include Laurent Sutton, Frédéric Davi, Frédéric Charlotte, Marc‐Olivier Bitker, Richard Dorent, Brigitte Autran, Nöel Milpied, Sylvain Choquet, Marine Diviné and Patrice Debré. Their work appears in journals such as Blood, Leukemia, Annals of Oncology, Journal of Clinical Oncology and Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact